GlassScriptPhysician profile
George Pisimisis
NPI 1538288311
$21,986.69
in general payments reported to CMS, 2019-2025
23 companies · $1,143 in 2025
The $1,143 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $210 · 2021: $25.90 · 2022: $30.50 · 2023: $10K · 2024: $11K · 2025: $1,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $19K · Food and Beverage: $1,720 · Travel and Lodging: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $19,250.00 |
| Food and Beverage | $1,720.34 |
| Travel and Lodging | $750.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $19,490.08 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $965.69 | 2021-2025 | Ellipsys Vascular Access System, Endurant Iis, Hawkone |
| Abbott Laboratories | $220.61 | 2024-2025 | Esprit, Freestyle Libre 3 |
| Bard Peripheral Vascular, INC. | $216.07 | 2025 | Venclose Maven Catheter |
| Penumbra, INC. | $158.92 | 2025 | Penumbra System |
| W. L. Gore & Associates, INC. | $116.29 | 2020 | |
| Asahi Intecc USA, INC. | $104.20 | 2025 | Asahi Peripheral Vascular Wires |
| Endologix LLC | $100.00 | 2025 | Alto Abdominal Stent Graft System |
| Medtronic Vascular, INC. | $93.25 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $66.73 | 2024 | Arcalyst |
| Atricure, INC. | $65.73 | 2024 | |
| Ge Healthcare | $63.73 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.19 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $41.44 | 2023-2024 | Inpefa |
| Baxter Healthcare | $37.57 | 2025 | Perclot |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.88 | 2024 | Lifevest |
| Tactile Systems Technology INC | $30.50 | 2022 | |
| Alnylam Pharmaceuticals INC. | $26.67 | 2024 | Amvuttra |
| Lilly USA, LLC | $25.21 | 2024 | Zepbound, Jardiance |
| Abiomed | $22.15 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $19.57 | 2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $18.97 | 2024 | Farxiga |
| Boston Scientific Corporation | $18.24 | 2023 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Pisimisis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.